Its in the Genes – Illumina
- Posted by Greg Harmon
- on June 23rd, 2014
The biotech space was red hot until earlier this year. then it became icy cold. But some names are coming back and starting to look ready for the next leg higher. One of them Illumina, $ILMN, just missed being the Premium Service Top 10 this week. The only reason it was not involved was that the other name that replaced it had more upside potential. With Monday in the books neither one fared well, but Illumina remains on watch for a move up. Take a look at the chart.
The chart above shows a Cup and Handle pattern that has been building since mid March. It looked promising for a break higher after a minor pullback and reversal last week, but Monday put a pause in the plan. What makes it worth continuing to follow is that the Cup and Handle pattern carries a target of a move to 228 if it can get back over 178. The company reports July 22nd so you have a month to get it going and can be safe without worrying about an earnings catalyst using the July Options chain. At the time of this writing the July 175 Calls were offered at $4.90, making for a low cost defined risk trade. I would still wait for the trigger.
Get my book, Trading Options: Using Technical Analysis to Design Winning Options Trades.
____________________________________________________________________________________________________
Want to learn more about Dragonfly Capital Views?
Dragonfly Capital Views Performance Through June 2014 Expiry and sign up here
If you like what you see above sign up for deeper analysis and trading strategy by using the Get Premium button above. As always you can see details of individual charts and more on my StockTwits page.
The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.
blog comments powered by Disqus-
Gregory W. Harmon CMT, CFA, has traded since 1986 and held senior positions including Head of Global Trading, Head of Product Development, Head of Strategy and Director of Equity. (More)
